SHANGHAI, China, Nov. 19 /PRNewswire/ -- ChinaBio(R) Accelerator today announced it is organizing the first partnering forum focused on China life science technology to be held in China. The ChinaBio(R) Partnering Forum, scheduled for June 3 and 4, 2009 in Shanghai, will bring together more than 300 attendees seeking to enter into partnership deals. The two-day forum will feature one-on-one partnering meetings, technology presentations by China-based researchers and biotech companies, big pharma leaders discussing their "wish lists," executive workshops and exhibits.
Technology areas represented will include: novel targets, leads and molecules, biomarkers, diagnostics, drug development platforms, drug delivery systems and medical devices. All technologies will be pre-screened by ChinaBio(R) to ensure the highest quality presentations and partnering opportunities.
To date, ChinaBio(R)-produced events have helped early and mid-stage biotech companies in China to access over $60 million US and close partnering deals with leading pharmaceutical companies including Pfizer, Roche, Lilly and Merck.
"China is the fastest growing market for pharmaceuticals in the world and now is transforming itself into an internationally-recognized leader in biotech innovation," said Greg Scott, President and founder of ChinaBio(R). "China biotech is clearly poised for global success because of its significant number of highly skilled scientists and innovators coupled with strong government support and a unique low cost, high quality development structure. We are now very pleased to announce our first Partnering Forum to be held in China and look forward to expanding on the success of our prior events here."
More details on the ChinaBio(R) Partnering Forum are available on the website http://www.CBPF2009.com.
About ChinaBio(R) Accelerator
ChinaBio(R) Accelerator is an operating unit of ChinaBio(R) LLC, which has offices in Shanghai, Palo Alto, California, and San Diego, California. The organization is committed to furthering opportunities for the emerging Chinese biotech industry by funding and mentoring early stage China-based life science companies, and leveraging its established cross-borders life science network to help companies secure high value partnerships and make the transition to the global market. For further information: http://www.chinabiollc.com
Contacts: ChinaBio(R) Accelerator Greg Scott 858.866.9309 firstname.lastname@example.org For ChinaBio(R) Accelerator Jennifer Larson 415.725.2017 email@example.com
Copyright©2008 PR Newswire.
All rights reserved